0.7500CAD0.00%Mkt Cap: 13.96M CADP/E: —Last update: 2026-05-29
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commerc…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap13.96M CAD
Enterprise Value7.75M CAD
Revenue (TTM)23.22M CAD
Gross Profit11.11M CAD
Net Income (TTM)-92.00K CAD
Revenue/Share1.238 CAD
Last Price0.7500 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-119.25
EV/Revenue0.33
P/S0.60
P/B0.97
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.400095% of range0.7700
52W High0.7700 CAD
52W Low0.4000 CAD
Profitability
Gross Margin52.60%
Oper. Margin-21.38%
EBITDA Margin-0.28%
Profit Margin-0.44%
ROE-0.59%
ROA-0.45%
Growth
Revenue Growth59.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.07M CAD
CapEx (TTM)333.00K CAD
FCF Margin-4.23%
FCF Yield-7.03%
Net Debt-6.21M CAD
Net Debt/EBITDA95.52
Balance Sheet
Debt/Equity0.02
Current Ratio2.81
Quick Ratio2.00
Book Value/Sh0.7750 CAD
Cash/Share0.4680 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.61M
Float16.11M
Insiders24.09%
Institutions0.88%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short463
Short (prev mo.)463
Technical
SMA 500.7502 (-0.0%)
SMA 2000.5431 (+38.1%)
Beta-0.14
S&P 52W Chg27.70%
Avg Vol (30d)10.51K
Avg Vol (10d)11.57K
Technical Indicators
RSI (14)54.8
MACD0.0058
MACD Signal0.0098
MACD Hist.-0.0040
BB Upper0.7664 CAD
BB Middle0.7570 CAD
BB Lower0.7476 CAD
BB Width2.48%
ATR (14)0.0037 CAD
Vol Ratio (20d)0.09x